Characterization of CD Responders to Vedolizumab
NCT04909359
·
clinicaltrials.gov ↗
COMPLETED
Status
51
Enrollment
OTHER
Sponsor class
Conditions
Crohn Disease
Ulcerative Colitis
Sponsor
University of Miami
Collaborators
[object Object]